|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00954 CHANGMAO BIO
Nominal 
0.445 -0.010 (-2.198%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 637,078 | -12.733% | 730,034 | 547,976 | 444,106 | 494,580 |
| Cost of Sales | (611,269) | 11.301% | (549,203) | (509,296) | (348,657) | (359,425) |
| Gross Profit | 25,809 | -85.728% | 180,831 | 38,680 | 95,449 | 135,155 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (183) | -- | 136 | (28) | 120 | 344 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (58,580) | -- | 87,644 | 84,409 | 17,152 | 62,553 | |
| Taxation | (27,938) | 344.448% | (6,286) | (26,202) | (409) | (4,626) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 461 | 609.231% | 65 | 111 | 84 | 372 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (86,057) | -- | 81,423 | 58,318 | 16,827 | 58,299 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 6,532 | 277.791% | 1,729 | 1,415 | (153) | 257 |
| Depreciation & Amortisation | 42,745 | 32.740% | 32,202 | 29,214 | 32,783 | 35,359 |
| Directors' Emoluments | 1,979 | -70.083% | 6,615 | 1,831 | 1,791 | 4,191 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -16.200 | -- | 15.400 | 11.000 | 3.200 | 11.000 |
| DPS (cts) | 0.000 | -- | 7.700 | 0.000 | 2.000 | 5.500 |
| Dividend Payout Ratio (%) | -- | -- | 50.000% | -- | 62.500% | 50.000% |
| Cash flow per share ($) | (0.004) | -- | 0.037 | (0.013) | 0.111 | 0.223 |
| NBV per share ($) | 1.230 | -- | 1.470 | 1.316 | 1.226 | 1.249 |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -18,786,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.035 |
| NBV Per Share (¥) | RMB 1.195 |